1. Home
  2. MYRG vs LEGN Comparison

MYRG vs LEGN Comparison

Compare MYRG & LEGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MYR Group Inc.

MYRG

MYR Group Inc.

N/A

Current Price

$273.33

Market Cap

4.0B

Sector

Industrials

ML Signal

N/A

Logo Legend Biotech Corporation

LEGN

Legend Biotech Corporation

N/A

Current Price

$16.30

Market Cap

4.6B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
MYRG
LEGN
Founded
1891
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Water Sewer Pipeline Comm & Power Line Construction
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.0B
4.6B
IPO Year
2008
2020

Fundamental Metrics

Financial Performance
Metric
MYRG
LEGN
Price
$273.33
$16.30
Analyst Decision
Strong Buy
Buy
Analyst Count
6
14
Target Price
★ $367.50
$40.93
AVG Volume (30 Days)
283.7K
★ 2.4M
Earning Date
10-28-2026
11-10-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 311.48
N/A
EPS
★ 9.97
N/A
Revenue
★ $1,531,169,000.00
N/A
Revenue This Year
$24.47
$38.78
Revenue Next Year
$14.89
$17.61
P/E Ratio
$26.81
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$199.31
$15.75
52 Week High
$503.57
$37.50

Technical Indicators

Market Signals
Indicator
MYRG
LEGN
Relative Strength Index (RSI) 47.78 36.01
Support Level $250.39 N/A
Resistance Level $290.32 $19.92
Average True Range (ATR) 13.82 1.40
MACD 0.81 -0.74
Stochastic Oscillator 59.27 8.25

Price Performance

Historical Comparison
MYRG
LEGN

About MYRG MYR Group Inc.

MYR Group Inc is a U.S. based holding company of specialty electrical construction service providers. Through its subsidiaries, it serves electric utility, commercial, and industrial construction markets in the United States and Canada, offering services such as design, engineering, procurement, construction, upgrades, maintenance, and repair, with a focus on construction, maintenance, and repair work. The company operates through two segments: Transmission and Distribution (T&D) and Commercial and Industrial (C&I). The majority of revenue is derived from the T&D segment, which provides a range of services on electric transmission and distribution networks and substation facilities, which include design, engineering, procurement, construction, upgrade and maintenance and repair services.

About LEGN Legend Biotech Corporation

Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.

Share on Social Networks: